Post sponsored by

MIL OSI Translation. Region: Russian Federation –

The defense Ministry of Russia jointly with the National research centre of epidemiology and Microbiology named after academician Gamalei has initiated clinical trials of the Russian combined vector vaccine designed for the prevention of novel coronavirus infection.

Permission to conduct clinical trials on the basis of the Main military clinical Burdenko hospital issued by the Ministry of health of the Russian Federation on June 16.

The results of the final screening among those on a two-week isolation volunteers conducted the final selection of the first group of participants consisting of 18 people that June 18 had been vaccinated. Nine volunteers entered one component of the vaccine, nine the second.

The introduction of the vaccine carried out under the control of the most experienced specialists of the Burdenko hospital, has repeatedly participated in the clinical trials of drugs and vaccines. Vaccination was in full compliance with the work plan without incident or complications.

Currently, the results of the survey and examination of the volunteers, adverse reactions or complications were not observed, complaints from participants on the health not.

After the introduction of the vaccine, the volunteers will continue to be under continuous supervision of medical professionals. There will be regular screenings, take necessary samples and tests.

A few days after a thorough research and obtain primary data on the safety and tolerability of the vaccine, immunization will be carried out the rest of the volunteers, which is currently also located in isolation under the supervision of medical specialists of the Burdenko hospital.

Testing a Russian vaccine against new coronavirus infection CoViD-19 are carried out jointly by the Ministry of defence and the National research centre of epidemiology and Microbiology them. N. F.Gamalei.

The vaccine trials on toxicity, safety, immunogenicity and protective efficacy on large and small animals performed in 48 Central research Institute of the Ministry of defense of Russia.

26 may, in the course of the meeting via videoconference with Russian President Vladimir Putin, Minister of defense of the Russian Federation General of the army Sergei Shoigu reported that 48 Central research Institute of NBC defence troops of the Ministry of defence in cooperation with the National research centre of epidemiology and Microbiology named after N. F.Gamalei of the Ministry of health launched the development of a recombinant vaccine against the new coronavirus infection. Clinical studies will be completed by the end of July.

1 2 3 4 5

EDITOR’S NOTE: This article is a translation. Apologies should the grammar and/or sentence structure will not be perfect.

MIL OSI Russia News